跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ISOPROTERENOL HYDROCHLORIDE INJECTION USP
Authorized
STANDARD
ISOPROTERENOL HYDROCHLORIDE INJECTION USP
marcan pharmaceuticals inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
81a8451f03cfd444
Company
marcan pharmaceuticals inc
Type
Standard
Approval Details
Approval Id
81a8451f03cfd444
Drug Approval Canada Name
ISOPROTERENOL HYDROCHLORIDE INJECTION USP
Product Name
ISOPROTERENOL HYDROCHLORIDE INJECTION USP
Status
Marketed
Status Date
2020-12-11
Original Market Date
2020-12-11
Din
02502615
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous , Intramuscular , Intravenous
Schedule
Prescription
Ahfs
12:12.08.04
Atc Original
C01CA02 ISOPRENALINE
Atc Name
c 01 ca 02
Aig Number
0101873001
Company Name
marcan pharmaceuticals inc
Company Address
2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2
Active Ingredients
ISOPROTERENOL HYDROCHLORIDE
0.2 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
81a8451f03cfd444
Type
Standard
Back to Health Canada Approvals